Skip to main content
Premium Trial:

Request an Annual Quote

GenMark Submits ePlex Blood Culture ID Gram-Positive Panel for FDA Clearance

NEW YORK (GenomeWeb) – GenMark Diagnostics said Thursday that it has applied to the US Food and Drug Administration for clearance of its ePlex Blood Culture ID – Gram Positive (BCID-GP) panel.

It is the first of three blood culture panels being developed on the ePlex molecular sample-to-answer system for the diagnosis and management of bloodstream infections that can lead to sepsis, the firm said.

GenMark said that it anticipates FDA submission of a Gram Negative panel (BCID-GN) and a Fungal Pathogen panel (BCID-FP) in the third and fourth quarters of this year. GenMark recently initiated a clinical study for its BCID-GN panel and is in the final stages of preparation of a clinical study for its BCID-FP panel.

"The FDA submission of our ePlex BCID-GP panel marks an important milestone for GenMark, as we continue to expand our menu of multiplex molecular panels across multiple infectious diseases," Hany Massarany, GenMark's president and CEO, said in a statement.

In June 2017, GenMark received CE marking for its ePlex BCID gram-positive and gram-negative panels.

Also in June last year, the firm received 510(k) clearance for its ePlex instrument and Respiratory Pathogen Panel, which detects more than 20 viral and bacterial pathogens that commonly cause upper respiratory infections.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.